http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013143940-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_213e7b98bce3a9d6be9936049694fa1a
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-4716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
filingDate 2013-03-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5465a2dc5f6b528f7d7e140c2fa0b59c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fdb3cc63b15fc29c157a0a210d8c186
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6672b734a823f153b0d0907d7dc07373
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07c5e9df361fb256eba0a1180e38003d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aac3c1b93ab25a8a8909d19e5c4a3ed4
publicationDate 2013-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2013143940-A1
titleOfInvention New lung cancer molecular markers
abstract The invention provides a method of diagnosis and/or prognosis of lung cancer, the method comprising the steps of: (a) determining the level of a C4 activation fragment in a test sample, and (b) comparing the level of the test sample with the level of a C4 activation fragment detected in a control sample, wherein if the level of C4 activation fragment is higher than the level in a reference control, it is indicative that the subject suffers lung cancer or has a bad prognosis. The present invention further provides methods for determining the risk of suffering from lung cancer as well as for deciding whether to initiate a medical regimen and to determine the efficacy of said medical regimen, based on the determination of a C4 activation fragment. C4 activation fragment, used as marker, confers high sensitivity and specificity to the methods object of the invention.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018146232-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022171777-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3361256-A1
priorityDate 2012-03-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100899848-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100925147-B1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID320930
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394386

Total number of triples: 24.